Cargando…
Alpha-1 antitrypsin is a potential biomarker for hepatitis B
BACKGROUND: Function exertion of specific proteins are key factors in disease progression, thus the systematical identification of those specific proteins is a prerequisite to understand various diseases. Though many proteins have been verified to impact on hepatitis, no systematical protein screeni...
Autores principales: | Tan, Xu-fei, Wu, Shan-shan, Li, Shu-ping, Chen, Zhi, Chen, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120791/ https://www.ncbi.nlm.nih.gov/pubmed/21639939 http://dx.doi.org/10.1186/1743-422X-8-274 |
Ejemplares similares
-
Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer.
por: Sparos, L., et al.
Publicado: (1984) -
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018) -
Therapeutic potential of alpha-1 antitrypsin in human disease
por: Kim, Minsun, et al.
Publicado: (2018) -
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020) -
Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)